Project Grant HT94252410276
Award Date 9/1/24
Completion Date 8/31/28
Dollars Obligated $1.7M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Baltimore, MD 21218, USA
Similar Awards
- This $1,536,075 federal Project Grant awarded by the Defense Health Agency (CFDA 12.420 - Military Medical Research and Development program) supports proteomics research on atrioventricular septal defect in Down syndrome at The Johns Hopkins University. The award period runs from September 1, 2024 to August 31, 2028. The funding will allow Johns Hopkins to conduct basic, translational, and clinical research to improve understanding and treatment of this condition, which is a priority area for...
- The Johns Hopkins University was awarded a $320,165 project grant by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) effective October 1, 2025 through September 30, 2027. The award supports research investigating the relationship between social determinants of health, biological aging, and disease progression in multiple sclerosis (MS). This research is conducted at the institution's Baltimore, Maryland location and aligns with the Defense...
- The Johns Hopkins University received a $248,356 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Cardiometabolic Comorbidity and Outcomes in Multiple Sclerosis: A Polygenic Risk Score Approach". The award period runs from September 1, 2023 to August 31, 2025. The project aims to investigate medical solutions for the battlefield through innovative and impactful biomedical research....
- The Defense Health Agency (DHA) awarded The Johns Hopkins University a $616,150 Project Grant under the Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025, through August 31, 2028. The BOLSTER (Blast-Exposure Outcomes and Associated Long-Term Symptom Trajectories Related to Essential Recovery-Pathways) Biomarker Initiative supports biomedical research designed to advance healthcare solutions for military service members. This three-year research...
- Federal Grant Award Summary The Johns Hopkins University received a $1.4M Project Grant award from the Defense Health Agency's Military Medical Research and Development program (CFDA 12.420) effective September 1, 2025 through August 31, 2028. The grant funds the BOLSTER (Blast-Exposure Outcomes and Associated Long-Term Symptom Trajectories Related to Essential Recovery-Pathways) Biomarker Initiative, a three-year research investigation conducted in Baltimore, Maryland. This initiative addresses...
- The Johns Hopkins University will provide research services under a $724,845 Project Grant from the Defense Health Agency's Military Medical Research and Development program. Specifically, Johns Hopkins will conduct applied biomedical studies from June 2023 through May 2026 to regenerate chronically denervated muscle through development of an injectable myoblast scaffold. The Military Medical Research and Development program aims to transform military and public health through innovative...
- Federal Grant Award Summary The Johns Hopkins University received a $823,267 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) effective August 1, 2025 through July 31, 2028. The award funds research investigating mitochondrial heteroplasmy as a novel risk factor for myelodysplastic syndromes, a three-year biomedical research initiative conducted at the institution's Baltimore, Maryland facility. This research...
- The Defense Health Agency awarded The Johns Hopkins University a $818,750 Project Grant under the Military Medical Research and Development program (CFDA 12.420) to conduct research on "Immune System Disturbances After Borrelia Burgdorferi Infection". The project will take place over 3 years from August 1, 2023 to July 31, 2026. As a leading research university, Johns Hopkins has extensive experience providing biomedical research, public health initiatives, and scientific analysis to...
- The Department of Defense's Defense Health Agency awarded a $798,272 Project Grant to The Johns Hopkins University on March 15, 2025 under the Military Medical Research and Development program (CFDA 12.420). The grant will fund a 2-year research project to test the use of Wnt inhibitors as a potential therapeutic intervention to reverse TDP-43 dysfunction in amyotrophic lateral sclerosis (ALS). As a leading research institution, The Johns Hopkins University has a strong track record of...
- The Johns Hopkins University was awarded a $647,632 Project Grant from the Defense Health Agency under the Military Medical Research and Development program. The grant will fund a research project from August 1, 2023 to July 31, 2026 to leverage a precision medicine platform to predict novel therapies for malignant peripheral nerve sheath tumors. Through the support of basic, applied, and advanced biomedical research, the Military Medical Research and Development program aims to transform health...